Form 4: Atara Biotherapeutics CEO Sells Shares
Insider Transaction (Form 4)
Anhco Nguyen, President and CEO and a Director of Atara Biotherapeutics, Inc., sold 5,062 shares of common stock on August 17, 2026 for $8.08 per share.
Summary
- Open-market sale: disposed of 5,062 Common Stock at $8.08 ($40,883) on August 17, 2026; holds 132,775 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $40,883 of stock on the open market.
Insider Transactions
Anhco Nguyen — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Open-market sale | Common Stock | 5,062 | $8 | $40.9K | 132,775 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Open-market sale (5,062 shares) |
Keywords
insider transaction, Form 4, ATRA, Atara Biotherapeutics, Inc., bearish, Anhco Nguyen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.